MSK-Leuk 1 - Human Premalignant Oral Leukoplakia Cell Line


Species: Human

Category: Premalignant cell line

Cancer Type: Oral Leukoplakia


MSK-Leuk 1 is a human oral leukoplakia cancer cell line.


This cell line was established from a female with oral leukoplakia.

Lead Researcher/Research Laboratory

  • Peter G. Sacks, MD, former Associate Attending, Surgery, Memorial Hospital, Memorial Sloan Kettering Cancer Center

Key References

PubMed=8842478; DOI=10.1007/BF00049486 Sacks P.G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.Cancer Metastasis Rev. 15:27-51(1996)


This cell line may be licensed nonexclusively for research or commercial purposes.

For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.

To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.

For licensing requests for a commercial purpose:  Contact MSK’s Tangible Materials team at [email protected].

For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354[email protected]

Stage of Development

Ready to use